| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EYPT | Common Stock | Options Exercise | $0 | +20,000 | +15% | $0.000000 | 155,441 | 09 Feb 2024 | Direct | |
| transaction | EYPT | Common Stock | Options Exercise | $0 | +17,534 | +11% | $0.000000 | 172,975 | 09 Feb 2024 | Direct | |
| transaction | EYPT | Common Stock | Tax liability | $229,306 | -7,962 | -4.6% | $28.80 | 165,013 | 09 Feb 2024 | Direct | F1 |
| transaction | EYPT | Common Stock | Tax liability | $201,053 | -6,981 | -4.2% | $28.80 | 158,032 | 09 Feb 2024 | Direct | F1 |
| transaction | EYPT | Common Stock | Gift | $0 | -74,681 | -47% | $0.000000 | 83,351 | 13 Feb 2024 | Direct | F2 |
| transaction | EYPT | Common Stock | Gift | $0 | +74,681 | +143% | $0.000000 | 126,889 | 13 Feb 2024 | By Family Trust | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EYPT | Restricted Stock Units | Options Exercise | $0 | -17,534 | -100% | $0.000000* | 0 | 09 Feb 2024 | Common Stock | 17,534 | $0.000000 | Direct | F4 |
| transaction | EYPT | Restricted Stock Units | Options Exercise | $0 | -20,000 | -50% | $0.000000 | 20,000 | 09 Feb 2024 | Common Stock | 20,000 | $0.000000 | Direct | F5 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | -3,116 | -67% | $0.000000 | 1,558 | 13 Feb 2024 | Common Stock | 3,116 | $12.90 | Direct | F6, F7 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | +3,116 | +4.4% | $0.000000 | 73,242 | 13 Feb 2024 | Common Stock | 3,116 | $12.90 | By Family Trust | F3, F6, F7 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | -4,452 | -7.1% | $0.000000 | 57,878 | 13 Feb 2024 | Common Stock | 4,452 | $13.13 | Direct | F6, F8 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | +4,452 | +2.9% | $0.000000 | 155,822 | 13 Feb 2024 | Common Stock | 4,452 | $13.13 | By Family Trust | F3, F6, F8 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | -5,000 | -3.8% | $0.000000 | 125,000 | 13 Feb 2024 | Common Stock | 5,000 | $10.13 | Direct | F6, F9 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | +5,000 | +4.5% | $0.000000 | 115,000 | 13 Feb 2024 | Common Stock | 5,000 | $10.13 | By Family Trust | F3, F6, F9 |
| Id | Content |
|---|---|
| F1 | No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| F2 | On February 13, 2024, the reporting person transferred owned shares of Common Stock of the Company to the Family Trust. |
| F3 | These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F4 | The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. |
| F5 | The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |
| F6 | On February 13, 2024, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share ("Common Stock"), of EyePoint Pharmaceuticals, Inc. (the "Company"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the "Family Trust"). |
| F7 | The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 28, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024. |
| F8 | The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025. |
| F9 | The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026. |